Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 7 (RPL31P7) is a human genomic sequence classified as a processed pseudogene, related to the functional ribosomal protein L31 gene (RPL31)[1][2][8]. Unlike the active RPL31 gene, which encodes a protein component of the ribosomal 60S large subunit and is essential for protein synthesis[7][10], RPL31P7 does not encode a functional protein and has no demonstrated biological activity or relevance as a therapeutic or diagnostic target[1][2][8][10]. The existence of RPL31P7, like many ribosomal protein pseudogenes, is considered a byproduct of evolutionary genomic processes such as gene duplication and retrotransposon activity rather than functional necessity[8]. As such, RPL31P7 should not be considered a target for pharmacological or therapeutic research. Note: If the intended target was the functional ribosomal protein L31 gene (RPL31), that would be a structural ribosomal protein with well-described cellular roles, but RPL31P7 specifically refers to a nonfunctional pseudogene[1][2][8].
None applicable (No mechanism of action since it is not an active gene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 7 (RPL31P7).